FDA Finalizes Guidance on Mandatory Recall Authority

Nov 06, 2018 | Michelle Shapiro

The U.S. Food and Drug Administration (FDA) has released a final guidance regarding the agency’s mandatory recall authority under the FDA Food Safety Modernization Act (FSMA).

The 2011 food safety law gave FDA mandatory recall authority for foods if there is a reasonable probability that the food is adulterated or misbranded under certain FDA authorities, and that the food could cause serious illnesses or death. FDA must give the responsible party an opportunity to conduct a voluntary recall before ordering a mandatory recall. Prior to the enactment of FSMA, FDA could only rely on manufacturers to voluntarily recall certain potentially harmful food products.

This final guidance follows a draft which was made available for public comment in 2015, and provides additional clarity including some modifications based on comments received. The guidance provides questions and answers on FDA’s mandatory recall process, explains what FDA considers when moving forward with a mandatory recall, and more.

FDA has issued a mandatory recall order of a food product only once. In April 2018, FDA issued a mandatory recall order for all food products containing powdered kratom manufactured, processed, packed, or held by Triangle Pharmanaturals LLC, after several products were found to contain Salmonella. In two other instances, FDA started down the path of using its mandatory recall authority under FSMA until the companies ultimately chose to voluntarily recall their product.

While FDA’s mandatory recall authority plays an important role in ensuring that potentially dangerous food products are removed from the marketplace, the agency remains committed to working with firms to facilitate the orderly and prompt voluntary removal of potentially dangerous products from the food supply. FDA Recall Coordinators are available to assist firms during the recall process.

For More Information


636530147572900000

About Michelle Shapiro

Michelle Shapiro is a communication specialist for the Environmental Health & Disability team at NACCHO.

More posts by Michelle Shapiro

Related Posts

Coronavirus COVID 19
  • COVID-19
  • Tools & Resources
  • Research & Reports

Environmental Health & COVID-19 Resource Roundup:...

As part of the National Association of County and City Health Officials’...

Jan 19, 2021 | Anu Varma

Environmental Health & COVID-19 Resource Roundup:...

Viral hepatitis logo
  • HIV, STI, & Viral Hepatitis

HHS Releases National Plan for Hepatitis Elimination

On January 7, 2021, the U.S. Department of Health and Human Services (HHS)...

Jan 19, 2021 | Kat Kelley

HHS Releases National Plan for Hepatitis Elimination

Si neisseria gonorrhoeae
  • Funding Opportunity
  • HIV, STI, & Viral Hepatitis

Funding Opportunity: Pharyngeal Gonorrhea Test of Cure...

NACCHO will fund up to 4 local health departments (LHDs) up to $100,000 each to...

Jan 19, 2021 | Rebekah Horowitz

Funding Opportunity: Pharyngeal Gonorrhea Test of Cure...

Capitol Building
  • Press Release
  • Immunization

NACCHO Statement on President-Elect Biden’s American...

NACCHO’s Statement on President-Elect Biden’s American Rescue & Vaccine Plans...

Jan 19, 2021 | Andrea Grenadier

NACCHO Statement on President-Elect Biden’s American...

Doctor 563428 640
  • COVID-19
  • Health in All Policies
  • Leadership
  • Workforce Development

Preparing Your Local Health Department for the Future

If the pandemic has taught us one thing, it is the importance of preparedness....

Jan 15, 2021 | Guest Author

Preparing Your Local Health Department for the Future

Covid
  • COVID-19
  • Immunization

Dosing intervals for COVID-19 mRNA Vaccine

On January 6, CDC revised Interim Clinical Considerations for Use of mRNA...

Jan 14, 2021 | Beth Hess

Dosing intervals for COVID-19 mRNA Vaccine

  • Opportunity

APHA 2021 Call for Abstracts is Open

Submit an abstract to present and share research with public health leaders and...

Jan 13, 2021 | Anu Varma

APHA 2021 Call for Abstracts is Open

CRC Sim PLER
  • Webinar
  • Emergency Response

CRC SimPLER: A Practice Workshop

To introduce CRC SimPLER, ASTHO and the National Alliance for Radiation...

Jan 11, 2021 | Beth Hess

CRC SimPLER: A Practice Workshop

Coronavirus COVID 19
  • COVID-19
  • Tools & Resources
  • Epidemiology

COVID-19 Genomic Epidemiology Toolkit

The CDC Office of Advanced Molecular Detection (AMD) recently released the...

Jan 11, 2021 | Beth Hess

COVID-19 Genomic Epidemiology Toolkit

Back to Top